Aemetis price target lowered to $2.50 from $5.00 at Truist

Truist analyst Jordan Levy lowered the firm’s price target on Aemetis to $2.50 from $5.00 and keeps a Hold rating on the shares. The company has structured a comprehensive renewable fuels growth strategy that could stand to see significant Inflation Reduction Act-driven upside, but Aemetis also continues to contend with limited liquidity, near-term redemptions and maturities, as well as ethanol market headwinds, the analyst tells investors in a research note.